Search Results 911-920 of 17600 for Assay
The purpose of this study is to validate the Alzheimer Disease Biomarkers assays (Phospho-Tau/Total-Tau/Ab42) being implemented at Mayo to compare them to the ...
... assays may be conducted. Patient must consent to provision of a sample of blood in order that the specific correlative marker assays may be conducted.
≥ 10% bone marrow plasma cells AND · Abnormal serum free light chain (FLC) ratio (< 0.26 or > 1.65) by serum FLC assay AND · Monotypic Plasma Cell S-phase ≥0.3%.
Positive anti-mitochondrial antibody (AMA) titers (>1/40 on immunofluorescence or M2 positive by enzyme linked immunosorbent assay [ELISA]) or positive PBC- ...
In vitro assays to evaluate repair capacity of tumors. Dr. Schellenberg uses the latest techniques in recombinant protein expression and biological ...
Measurable disease defined by any of following: Serum M-protein > 1 g/dL; Urine M-protein > 200 mg/24h; Serum free light chain (FLC) assay: involved FLC ...
... assays using patient peripheral blood immune cells or serum. cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal ...
• Nathaniel Traaseth Growth inhibition assays in pathogenic bacteria. Subject to Laboratory and Animal Biosafety Level 2 provisions and practices for ...
Serum free light chain (FLC) assay: involved FLC level ≥ 10 mg/dL provided serum FLC ratio is abnormal;; In cases where SPEP is unreliable, serum ...
The team also uses a new laboratory test called seed amplification assay to detect the presence of alpha-synuclein. By identifying sex-specific patterns in ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift to celebrate this day advances our doctors’ lifesaving work.